Thank you for the question.
For the first recommendation, which was around supporting further procurement decisions, we are finalizing the development of a framework in the interpandemic period to help us systematically support decision-making on any potential future procurement of H5 vaccines for humans.
That framework will include considerations such as the availability of vaccinations from manufacturers and production timelines; ongoing monitoring of other potential suppliers and international partners in terms of their procurement plans and supply readiness; consultation with our expert panel on avian influenza regarding needs and evidence, including an epidemiological review of risk conditions and the stage of our preparedness as a whole; and consultations, obviously, with provinces and territories on their potential needs or objectives from a public health protection perspective. That's the first response.
Regarding the second piece around recommendations related to improving the management of vaccine distribution and monitoring, there are a couple of things.
First, we have already transitioned away from using Vaccine Connect, the previous system for vaccine supply monitoring, which was federally procured. We integrated that functionality into our agency's warehouse management IT system. This enables us to track, in near to real time, integrated information on pandemic vaccines from manufacturers in terms of full visibility of supply distribution and wastage in the context of suppliers. We are continuing to work on improving vaccine distribution and monitoring, and onboarding pandemic vaccine manufacturers and vendors into this system so it will be ready if we need to use it. That's if we have additional supply.
The second most important piece here is the recommendation related to information sharing with provinces and territories. We're in the process of finalizing a public health information-sharing agreement with provinces and territories that scopes very much beyond vaccines. However, one of those areas is vaccines. That's obviously key to supporting information sharing.
Thank you.